Literature DB >> 16041053

Similarity of gene expression patterns in human alveolar macrophages in response to Pseudomonas aeruginosa and Burkholderia cepacia.

Stefan Worgall1, Adriana Heguy, Karsta Luettich, Timothy P O'Connor, Ben-Gary Harvey, Luis E N Quadri, Ronald G Crystal.   

Abstract

To determine if differences in the severity of pulmonary infection in cystic fibrosis seen with late isolates of Pseudomonas aeruginosa and Burkholderia cepacia are associated with differences in the initial response of alveolar macrophages (AM) to these pathogens, we assessed gene expression changes in human AM in response to infection with a laboratory strain, early and late clinical isolates of P. aeruginosa, and B. cepacia. Analysis of gene expression changes at the RNA level using oligonucleotide microarrays, following exposure to laboratory P. aeruginosa strain PAK, showed significant (P < 0.01) >2.5-fold upregulation of 42 genes and >2.5-fold downregulation of 45 genes. The majority of the changes in gene expression involved genes as part of inflammatory pathways and signaling systems. Interestingly, similar responses were observed following exposure of AM to early and late clinical isolates of P. aeruginosa, as well as with B. cepacia, suggesting that the more severe clinical outcome of infections with late clinical isolates of P. aeruginosa or with B. cepacia cannot be explained by differences in the early interactions of these organisms with the human AM, as reflected by the similarity of gene expression changes in response to exposure of AM to these pathogens.

Entities:  

Mesh:

Year:  2005        PMID: 16041053      PMCID: PMC1201277          DOI: 10.1128/IAI.73.8.5262-5268.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  42 in total

Review 1.  Post-analysis follow-up and validation of microarray experiments.

Authors:  Rodrigo F Chuaqui; Robert F Bonner; Carolyn J M Best; John W Gillespie; Michael J Flaig; Stephen M Hewitt; John L Phillips; David B Krizman; Michael A Tangrea; Mamoun Ahram; W Marston Linehan; Vladimir Knezevic; Michael R Emmert-Buck
Journal:  Nat Genet       Date:  2002-12       Impact factor: 38.330

Review 2.  Opinion: Interpretation of the complexity of innate immune responses by functional genomics.

Authors:  Paola Ricciardi-Castagnoli; Francesca Granucci
Journal:  Nat Rev Immunol       Date:  2002-11       Impact factor: 53.106

3.  The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils.

Authors:  Kazuhiro Tateda; Yoshikazu Ishii; Manabu Horikawa; Tetsuya Matsumoto; Shinichi Miyairi; Jean Claude Pechere; Theodore J Standiford; Masaji Ishiguro; Keizo Yamaguchi
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

Review 4.  An overview of the pathogenesis of cystic fibrosis lung disease.

Authors:  R C Boucher
Journal:  Adv Drug Deliv Rev       Date:  2002-12-05       Impact factor: 15.470

5.  Pseudomonas aeruginosa cystic fibrosis isolates induce rapid, type III secretion-dependent, but ExoU-independent, oncosis of macrophages and polymorphonuclear neutrophils.

Authors:  D Dacheux; B Toussaint; M Richard; G Brochier; J Croize; I Attree
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

Review 6.  Cystic fibrosis.

Authors:  Felix Ratjen; Gerd Döring
Journal:  Lancet       Date:  2003-02-22       Impact factor: 79.321

7.  Effects of Cl2MDP-encapsulating liposomes in a murine model of Pseudomonas aeruginosa-induced sepsis.

Authors:  Junichi Fujimoto; Jeanine P Wiener-Kronish; Satoru Hashimoto; Teiji Sawa
Journal:  J Liposome Res       Date:  2002       Impact factor: 3.648

Review 8.  Pathophysiology and management of pulmonary infections in cystic fibrosis.

Authors:  Ronald L Gibson; Jane L Burns; Bonnie W Ramsey
Journal:  Am J Respir Crit Care Med       Date:  2003-10-15       Impact factor: 21.405

9.  Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement.

Authors:  I-Hsin Su; Ashwin Basavaraj; Andrew N Krutchinsky; Oliver Hobert; Axel Ullrich; Brian T Chait; Alexander Tarakhovsky
Journal:  Nat Immunol       Date:  2002-12-23       Impact factor: 25.606

Review 10.  Second messenger pathways in pulmonary host defense.

Authors:  Martha M Monick; Gary W Hunninghake
Journal:  Annu Rev Physiol       Date:  2002-05-01       Impact factor: 19.318

View more
  5 in total

1.  Proinflammatory phenotype and increased caveolin-1 in alveolar macrophages with silenced CFTR mRNA.

Authors:  Yaqin Xu; Anja Krause; Hiroko Hamai; Ben-Gary Harvey; Tilla S Worgall; Stefan Worgall
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

2.  Design of a liposomal candidate vaccine against Pseudomonas aeruginosa and its evaluation in triggering systemic and lung mucosal immunity.

Authors:  Béatrice Heurtault; Philippe Gentine; Jean-Sébastien Thomann; Corinne Baehr; Benoît Frisch; Françoise Pons
Journal:  Pharm Res       Date:  2008-09-10       Impact factor: 4.200

3.  Analysis of Genome-scale Expression Network in Four Major Bacterial Residents of Cystic Fibrosis Lung.

Authors:  Nazanin Hosseinkhan; Peyman Zarrineh; Ali Masoudi-Nejad
Journal:  Curr Genomics       Date:  2014-10       Impact factor: 2.236

4.  Mapping genetic determinants of host susceptibility to Pseudomonas aeruginosa lung infection in mice.

Authors:  Maura De Simone; Lorenza Spagnuolo; Nicola Ivan Lorè; Cristina Cigana; Ida De Fino; Karl W Broman; Fuad A Iraqi; Alessandra Bragonzi
Journal:  BMC Genomics       Date:  2016-05-11       Impact factor: 3.969

Review 5.  Transcriptome Profiling and Molecular Therapeutic Advances in Cystic Fibrosis: Recent Insights.

Authors:  Justin E Ideozu; Xi Zhang; Susanna McColley; Hara Levy
Journal:  Genes (Basel)       Date:  2019-02-26       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.